Highlights
A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.
Displaying items 1-12 of 157
» View wsbt.com items only
1
2
3
4
5
6
7
8
9
10
11-14
•
Next >
-
Drug may slow growth of early prostate cancer
Researchers say that a drug used to treat enlarged prostates may also slow the growth of tumors in men with low-risk prostate cancer who opt to be monitored instead of getting treated right away. A study found that men taking the drug Avodart were...Tags: Florida, Drugs and Medicines, Diseases and Illnesses, Medical Research, Cancer
-
Dow, S&P end at records on Fed officials' reassurance
ReutersNEW YORK (Reuters) - Stocks rose on Tuesday, with the Dow and the S&P 500 closing at new all-time highs as Federal Reserve officials' comments eased some concerns that the central bank could start reducing its stimulus program. Dow component Home Depot...Tags: St. Petersburg (Pinellas, Florida), Websense Incorporated, Mutual Funds, Westport, Level 3 Communications Incorporated
-
Royalty eleva oferta por Elan, emite ultimátum a accionistas
ReutersPor Padraic Halpin y Jessica Toonkel DUBLIN/NUEVA YORK (Reuters) - Royalty Pharma elevó su oferta hostil por Elan a 12,50 dólares por acción y amenazó con retirar la oferta si los accionistas de Elan aprueban una serie de transacciones defensivas...Tags: Theravance Incorporated, Elan Corporation Plc
-
US high-yield issuers rush to market
ReutersBy Joy Ferguson and Rachelle Kakouris May 20 (IFR) - It's looking like another busy week for high-yield as issuers rush in ahead of the long Memorial Day weekend to take advantage of the current window for issuance at near-record low coupons. A total...Tags: Morgan Stanley Dean Witter & Company, Century Aluminum Company, Radiation Therapy, Goldman Sachs Group, Inc., Theravance Incorporated
-
XenoPort to drop multiple sclerosis drug, shares fall
Reuters(Reuters) - XenoPort Inc said it would stop development of an experimental multiple sclerosis treatment it planned to launch in 2015 after a late-stage trial failed to show significant improvement over a placebo. Shares of the company fell 26 percent...Tags: New Products, Environmental Issues, Biogen Idec Incorporated, Food and Drug Administration, Acorda Therapeutics Incorporated
-
Royalty raises Elan bid, issues ultimatum to shareholders
ReutersDUBLIN/NEW YORK (Reuters) - Royalty Pharma raised its hostile bid for Elan to $12.50 per share and threatened to withdraw the bid if Elan shareholders approve a series of defensive transactions announced by the Irish drug firm. Royalty Pharma, which buys...Tags: Alzheimer's Disease, Business Enterprises, Theravance Incorporated, Biogen Idec Incorporated, Companies and Corporations
-
Timeline: An attorney and anthrax
May 2001: Washington lawyer Richard J. Danzig is appointed to the board of Human Genome Sciences Inc. in Rockville, Md. Sept. 11, 2001: Terrorists crash passenger jets into the World Trade Center in New York, the Pentagon and rural Pennsylvania. Soon...Tags: Human Genome Sciences Inc., U.S. Congress, Rockville (Bethlehem, Pennsylvania), Anthrax
-
Pointing to threat, pulling in profit
Tribune Washington BureauWASHINGTON -- Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a...Tags: National Institutes of Health, Defense, Science, Human Genome Sciences Inc., White House
-
Spotlighting a terrorism risk, and profiting
WASHINGTON — Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he...
Tags: National Institutes of Health, Defense, Science, Human Genome Sciences Inc., White House
-
Espionage, comedy veterans touted for upcoming U.S. TV season
ReutersBy Liana B. Baker NEW YORK, May 16 (Reuters) - The big four U.S. broadcast networks, in need of new TV hits to turn around slumping ratings, are betting espionage programs and old comedy stars will convince advertisers to spend about $9 billion during...Tags: Marketing, Jerry Bruckheimer , Fox Broadcasting Company, FBI, Television Industry
-
Espionage, comedy veterans touted for upcoming TV season
ReutersNEW YORK (Reuters) - The big four U.S. broadcast networks, in need of new TV hits to turn around slumping ratings, are betting espionage programs and old comedy stars will convince advertisers to spend about $9 billion during the so-called upfront selling...Tags: Marketing, Jerry Bruckheimer , FBI, Fox Broadcasting Company, Television Industry
-
Chief executives and the itch to quit
ReutersLONDON (Reuters) - On approaching his 60th birthday this year, long-serving Tullow Oil boss Aidan Heavey told staff he felt "like two 30 year-olds". A handful of recent shock departures by 50-something chief executives at European blue chip companies -...Tags: Blue Chip Stocks, Corporate Officers, ABB Ltd., Delhaize Group, Diageo Plc
Feb 15, 2011
|Story| AP Broadcast
May 21, 2013
|Story| Reuters
May 20, 2013
|Story| Reuters
May 20, 2013
|Story| Reuters
May 20, 2013
|Story| Reuters
May 20, 2013
|Story| Reuters
May 19, 2013
|Story| Los Angeles Times
May 19, 2013
|Story| Los Angeles Times
May 19, 2013
|Story| Los Angeles Times
May 16, 2013
|Story| Reuters
May 16, 2013
|Story| Reuters
May 16, 2013
|Story| Reuters
Original site for GlaxoSmithKline PLC topic gallery.